06978.HK
Immunotech Biopharm Ltd
HKSE · Healthcare · Biotechnology · CN
HKD 0.36
+1.41%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
201.6%
Return on equity
-35.2%
Return on assets
-48.7%
Return on invested capital
0.00x
Asset turnover
-HKD 142.0M
Cash from operations
HKD 0.14
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026